Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes

Remco van Horssen1, Alexander M M Eggermont, Timo L M ten Hagen

  • 1Laboratory of Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus University MC - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. r.vanhorssen@ncmls.ru.nl

Insights

Endothelial monocyte-activating polypeptide-II (EMAP-II) is a cytokine involved in inflammation and angiogenesis. This review covers EMAP-II

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Endothelial monocyte-activating polypeptide-II (EMAP-II) is a pro-inflammatory cytokine.
  • Its precursor, proEMAP/p43, is linked to protein translation via the tRNA multisynthetase complex.
  • Both proEMAP/p43 and EMAP-II exhibit cytokine properties and affect various cell types.

Purpose of the Study:

  • To review existing data on the isolation, expression, and functions of EMAP-II.
  • To explore EMAP-II's roles in physiological and pathological conditions, particularly cancer.
  • To discuss proEMAP/p43 processing into EMAP-II and potential therapeutic applications.

Main Methods:

  • Literature review of published data.
  • Analysis of studies on EMAP-II isolation and expression.
  • Examination of research on EMAP-II functions in various cell types and disease models.

Main Results:

  • EMAP-II possesses pro-inflammatory and anti-angiogenic activities.
  • ProEMAP/p43, the precursor, also has cytokine properties and is involved in translation.
  • EMAP-II and its precursor impact endothelial cells, immune cells, and fibroblasts.

Conclusions:

  • EMAP-II is a multifunctional cytokine with significant roles in both normal physiology and disease, especially cancer.
  • Understanding the processing of proEMAP/p43 to EMAP-II is crucial.
  • EMAP-II holds potential for novel cancer therapies.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...